See also this year's filing and all EDGAR filings for this company.
PDF Report 0001351288_2020_GW_PHARMACEUTICALS_PLC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001351288')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001351288, GW PHARMACEUTICALS PLC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 699,636,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 6,959,000 |
| 2 | PropertyPlantAndEquipmentNet | 127,765,000 |
| 3 | remainder_Assets | 47,889,000 |
| 4 | LiabilitiesCurrent | 117,561,000 |
| 5 | LiabilitiesNoncurrent | 38,654,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 27,199,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 259,880,000 |
| 9 | ResearchAndDevelopmentExpense | 142,678,000 |
| 10 | remainder_Expenses | 903,000 |
| 11 | remainder_Revenues | 415,449,000 |
| 12 | remainder_NetIncome | 6,192,000 |
| 13 | remainder_ComprehensiveNetIncome | 10,065,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 882,249,000 |
| 1 | Liabilities | 156,215,000 |
| 2 | Expenses | 430,660,000 |
| 3 | Revenues | 415,449,000 |
| 4 | StockholdersEquity | 726,034,000 |
| 5 | NetIncome | -9,019,000 |
| 6 | ComprehensiveNetIncome | -3,986,500 |
| 7 | BaseVar | 950,415,000 |
| 8 | EconomicCapitalRatio | 2.40 |
Edgar->Model Mapping
Feature Distribution
Change over Time
